NextCure Inc (NXTC)
1.56
-0.02
(-1.27%)
USD |
NASDAQ |
May 31, 16:00
1.545
-0.02
(-0.96%)
After-Hours: 20:00
NextCure Cash from Operations (Quarterly): -12.61M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -12.61M |
| December 31, 2023 | -10.67M |
| September 30, 2023 | -12.78M |
| June 30, 2023 | -14.75M |
| March 31, 2023 | -14.78M |
| December 31, 2022 | -8.949M |
| September 30, 2022 | -15.00M |
| June 30, 2022 | -14.49M |
| March 31, 2022 | -15.45M |
| December 31, 2021 | -13.49M |
| September 30, 2021 | -12.66M |
| June 30, 2021 | -17.22M |
| March 31, 2021 | -13.91M |
| Date | Value |
|---|---|
| December 31, 2020 | -6.278M |
| September 30, 2020 | -15.67M |
| June 30, 2020 | -12.41M |
| March 31, 2020 | -10.59M |
| December 31, 2019 | -9.991M |
| September 30, 2019 | -7.947M |
| June 30, 2019 | -10.60M |
| March 31, 2019 | -7.08M |
| December 31, 2018 | 22.47M |
| September 30, 2018 | -4.719M |
| June 30, 2018 | -4.957M |
| March 31, 2018 | -4.803M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-17.22M
Minimum
Jun 2021
-6.278M
Maximum
Dec 2020
-12.51M
Average
-12.72M
Median
Cash from Operations (Quarterly) Benchmarks
| Assertio Holdings Inc | 7.508M |
| DiaMedica Therapeutics Inc | -6.653M |
| Terns Pharmaceuticals Inc | -22.80M |
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 17.88M |
| Cash from Financing (Quarterly) | 0.001M |
| Free Cash Flow | -51.41M |
| Free Cash Flow Per Share (Quarterly) | -0.4531 |
| Free Cash Flow Yield | -118.3% |